Daymark Wealth Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.33M Sell
58,766
-8,848
-13% -$808K 0.13% 127
2026
Q1
$6.94M Buy
67,614
+3,042
+5% +$343K 0.22% 90
2025
Q4
$8.09M Buy
64,572
+2,961
+5% +$377K 0.26% 78
2025
Q3
$8.25M Buy
61,611
+3,805
+7% +$499K 0.28% 72
2025
Q2
$7.86M Buy
57,806
+7,907
+16% +$1.04M 0.3% 69
2025
Q1
$6.62M Buy
49,899
+592
+1% +$75.3K 0.28% 76
2024
Q4
$5.58M Sell
49,307
-716
-1% -$82.7K 0.24% 89
2024
Q3
$5.7M Sell
50,023
-1,835
-4% -$201K 0.24% 88
2024
Q2
$5.39M Buy
51,858
+4,386
+9% +$465K 0.25% 89
2024
Q1
$5.4M Sell
47,472
-889
-2% -$102K 0.29% 84
2023
Q4
$5.32M Buy
48,361
+317
+0.7% +$31.7K 0.33% 75
2023
Q3
$4.65M Buy
48,044
+2,937
+7% +$308K 0.32% 74
2023
Q2
$4.92M Buy
45,107
+2,442
+6% +$260K 0.37% 66
2023
Q1
$4.32M Sell
42,665
-17,811
-29% -$1.88M 0.57% 39
2022
Q4
$6.64M Buy
+60,476
New +$6.26M 1.17% 21

Other funds holding ABT

Daymark Wealth Partners's ABT Position: Q2 2026 in Review

Daymark Wealth Partners reduced its Abbott (ABT) stake by 13% in Q2 2026, selling an estimated $808K and leaving 58,766 shares worth $5.33M. The position accounts for 0.13% of the portfolio, ranked #127.

Daymark Wealth Partners first reported a position in ABT in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.25M in Q3 2025. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Daymark Wealth Partners held 58,766 shares of Abbott worth $5.33M as of Q2 2026.
  • Daymark Wealth Partners sold 8,848 Abbott shares in Q2 2026, an estimated $808K.
  • Abbott made up 0.13% of Daymark Wealth Partners's portfolio in Q2 2026, its #127 holding.
  • Daymark Wealth Partners first reported a position in Abbott in Q4 2022 and has held it in 15 quarters since.
  • Daymark Wealth Partners's Abbott position peaked at $8.25M in Q3 2025.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.